Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

ACC / WCC 2023

Summaries from ACC.23 Annual Scientific Session & Expo Together With World Congress of Cardiology, held from March 4 – 6, 2023.

Adding sotatercept to existing therapy provides a new treatment approach for pulmonary arterial hypertension

Presenter: Marius M. Hoeper, MD, Hannover Medical School, Hannover, Germany

Sotatercept added to existing therapy for pulmonary arterial hypertension induces significant improvements in exercise capacity and significantly reduces the risk of death or worsening of clinical events.

Older, overweight men are more likely to have asymptomatic atrial fibrillation

Presenter: Jessica Mao, MD, Cedars Sinai Medical Center, Los Angeles, CA

Older, overweight men are at higher risk for presenting with asymptomatic atrial fibrillation and, thus, may benefit from targeted atrial fibrillation screening.

Patch-based cardiac rhythm monitoring more accurately detects arrhythmias than multi- electrode system

Presenter: Lohit Garg, MD, University of Pennsylvania, Philadelphia, PA

An ambulatory patch-based cardiac rhythm monitoring system provides more accurate information for determining atrial fibrillation (AFib) than a multi-electrode, wire-based monitoring system.

Long-term continuous cardiac monitoring provides effective arrhythmia diagnoses in Medicare beneficiaries

Presenter: Suneet Mittal, MD, Valley Health System, Ridgewood, NJ

Ambulatory cardiac monitoring using long-term continuous monitoring tools more effectively diag-noses arrhythmias with both lower healthcare utilization and costs compared with other ambulato-ry monitoring systems, according to Medicare beneficiary data.

New ablation technology effectively treats atrial fibrillation

Presenter: Atul Verma, MD, McGill University Health Centre, Montreal, Canada

Pulsed field ablation, a new technology for atrial fibrillation ablation, has been shown to eliminate both persistent and paroxysmal atrial fibrillation for 12 months in up to 80% of patients with adverse event rates below 1%.

Artificial intelligence-assisted echocardiography can help novices screen for heart failure

Presenter: Feiqiong Huang, MD, PhD, National Heart Centre Singapore, Singapore

Artificial intelligence (AI)-assisted point-of-care echocardiography enables laypeople to perform accurate echocardiography screening for heart failure in most cases.

Next-generation Ambulatory ECG Monitor Delivers High-quality Clinical Data

Presenter: Jay H. Alexander, MD, of North Shore University Health System Faculty Practice, Evanston, IL

A lighter, more compliant next-generation ECG monitor may improve both patient and provider experience, with both standard 14-day and extended 30-day wear.

Sensors, Wearables and Remote Monitoring Help Provide Integrated Cardiology Care

Presenter: Ami Bhatt, MD, of Massachusetts General Hospital, Boston, MA

New wearables and remote monitoring in cardiology provide the promise for better integrated care to improve both clinical practice and patients’ quality of life.

Bempedoic Acid Improves Clinical Outcomes in Statin-Intolerant Patients

Presenter: Steven E. Nissen, MD, Cleveland Clinic, Cleveland, OH

The cholesterol-lowering drug bempedoic acid reduced the combined rate of major adverse cardiovascular events by 13% in a large trial of patients who were unable to tolerate statins.

 

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire